<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
<channel>
<title>Narcolepsy, Sleep, and Health Research, Center for </title>
<link>http://hdl.handle.net/10027/8250</link>
<description/>
<pubDate>Sat, 25 May 2013 03:13:32 GMT</pubDate>
<dc:date>2013-05-25T03:13:32Z</dc:date>
<item>
<title>Cognitive behavioral therapy for insomnia&#13;
comorbid with COPD is feasible with preliminary&#13;
evidence of positive sleep and fatigue effects</title>
<link>http://hdl.handle.net/10027/8273</link>
<description>Cognitive behavioral therapy for insomnia&#13;
comorbid with COPD is feasible with preliminary&#13;
evidence of positive sleep and fatigue effects
Kapella, Mary C.; Herdegen, James J.; Perlis, Michael L.; Shaver, Joan L.; Larson, Janet L.; Law, Julie A.; Carley, David W.
Background: Many people with COPD report difficulties falling asleep or staying asleep, insufficient sleep duration, or nonrestorative sleep. Cognitive behavioral therapy for insomnia (CBT-I) has proved effective not only in people with primary insomnia but also in people with insomnia comorbid with psychiatric and medical illness (eg, depression, cancer, and chronic pain). However, CBT-I has rarely been tested in those with COPD who have disease-related features that interfere with sleep and may lessen the effectiveness of such therapies. The purpose of this study was to determine the feasibility of applying a CBT-I intervention for people with COPD and to assess the impact of CBT-I on insomnia severity and sleep-related outcomes,&#13;
fatigue, mood, and daytime functioning.&#13;
Methods: The study had two phases. In Phase 1, a 6-weekly session CBT-I intervention protocol in participants with COPD was assessed to examine feasibility and acceptability. Phase 2 was a small trial utilizing a prospective two-group pre- and post-test design with random assignment to the six-session CBT-I or a six-session wellness education (WE) program to determine the effects of each intervention, with both interventions being provided by a nurse behavioral sleep medicine specialist.&#13;
Results: Fourteen participants (five in Phase 1 and nine in Phase 2) completed six sessions&#13;
of CBT-I and nine participants completed six sessions of WE. Participants indicated that both interventions were acceptable. Significant positive treatment-related effects of the CBT-I intervention were noted for insomnia severity (P = 0.000), global sleep quality (P = 0.002), wake after sleep onset (P = 0.03), sleep efficiency (P = 0.02), fatigue (P = 0.005), and beliefs and attitudes about sleep (P = 0.000). Significant positive effects were noted for depressed mood after WE (P = 0.005).&#13;
Conclusion: Results suggest that using CBT-I in COPD is feasible and the outcomes compare&#13;
favorably with those obtained in older adults with insomnia in the context of other chronic&#13;
illnesses.
© 2011 Dove Medical Press, originally published in the International Journal of Chronic Obstructive Pulmonary Disease.&#13;
DOI: 10.2147/COPD.S24858
</description>
<pubDate>Sat, 01 Jan 2011 06:00:00 GMT</pubDate>
<guid isPermaLink="false">http://hdl.handle.net/10027/8273</guid>
<dc:date>2011-01-01T06:00:00Z</dc:date>
</item>
</channel>
</rss>
